Letter to the editor: A reminder to screen for varices! Atezolizumab/bevacizumab for HCC
- 20 May 2022
- journal article
- letter
- Published by Wolters Kluwer Health in Hepatology
- Vol. 76 (4) , E78-E79
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world studyHepatology, 2022
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular CarcinomaNew England Journal of Medicine, 2020
- Combined locoregional-immunotherapy for liver cancerJournal of Hepatology, 2019